Skip to main content

Table 1 Baseline characteristics of study participants by age group and self-reported mammography frequency (n = 93,438)*

From: Mammography screening and mortality by risk status in the California teachers study

 

Age at baseline 40–49 (n = 31,398)

Age at baseline 50–59 (n = 28,342)

Age at baseline 60–74 (n = 25,674)

Age at baseline 75–85 (n = 8024)

 

Never/ Less frequent (Row%)

Biennial (Row%)

Annual (Row%)

Never/ Less frequent (Row%)

Biennial (Row%)

Annual (Row%)

Never/ Less frequent (Row%)

Biennial (Row%)

Annual (Row%)

Never/ Less frequent (Row%)

Biennial (Row%)

Annual (Row%)

Overall

18.8

35.3

46.1

7.6

22.9

69.0

8.2

22.3

69.6

15.2

29.4

55.4

Mean follow-up time (years)

18.7

18.9

18.8

17.8

17.9

18.0

15.6

16.2

16.7

9.7

11.3

12.0

Race/ethnicity

 White

17.6

35.1

47.3

7.5

22.2

70.3

8.1

21.8

70.1

15.0

29.0

56.0

 African American

22.3

38.0

39.7

7.0

29.4

63.6

6.6

27.0

66.5

18.7

35.3

46.0

 Hispanic

25.3

37.3

37.4

8.9

29.2

61.9

8.1

26.0

66.0

17.5

27.5

55.0

 Asian/Pacific Islander

22.5

36.7

40.7

8.3

27.0

64.6

10.0

27.0

63.0

11.5

41.0

47.4

 Other

26.0

33.1

40.9

12.2

26.0

61.8

11.5

25.5

62.9

17.2

32.1

50.7

Number of first-degree relatives diagnosed with breast cancer

 0

19.7

36.3

44.0

7.9

23.8

68.3

8.4

22.7

68.9

15.3

30.1

54.5

 1+

10.0

27.3

62.7

5.4

16.8

77.8

6.4

18.4

75.2

11.8

25.6

62.6

 Unknown

20.0

35.6

44.4

10.5

25.5

64.1

9.7

27.9

62.4

22.0

27.9

50.1

BMIa

 Underweight/normal

17.2

35.2

47.6

6.6

21.9

71.5

7.6

21.2

71.2

15.0

29.2

55.8

 Overweight

19.4

35.7

45.0

7.5

23.4

69.1

7.9

22.9

69.2

12.5

30.0

57.6

 Obese

23.1

34.8

42.1

10.8

25.3

63.8

9.2

24.0

66.8

16.4

32.6

51.0

 Unknown

21.3

38.8

39.9

10.5

26.0

63.5

12.9

23.9

63.2

20.1

26.9

53.0

Lifetime physical activity (hours/week/year)

 ≤0.5

17.9

35.9

46.1

8.7

23.8

67.5

9.8

23.2

67.0

18.3

29.0

52.6

 0.51–3.99

17.5

35.7

46.8

7.0

23.2

69.8

7.4

22.2

70.4

13.9

29.3

56.8

 ≥4.0

19.8

34.8

45.3

8.2

22.3

69.5

8.5

21.9

69.6

14.5

29.8

55.7

Menopause/Hormone therapy

 Premenopausal

21.3

35.4

43.3

12.0

26.9

61.1

23.1

38.5

38.5

–

–

–

 Postmenopausal - HT Never

22.6

34.8

42.6

21.1

27.8

51.1

17.9

26.4

55.7

24.4

31.7

43.8

 Postmenopausal - HT Former

15.6

36.5

47.9

10.8

29.1

60.1

10.1

26.5

63.3

14.1

31.4

54.5

 Postmenopausal - HT Current

7.9

35.0

57.1

3.3

20.1

76.6

3.2

19.0

77.8

6.9

25.5

67.6

 Other

11.3

35.0

53.6

5.5

21.9

72.7

8.4

23.2

68.4

15.9

29.6

54.5

Alcohol consumption

 None

21.3

34.7

44.0

9.2

23.8

67.0

10.2

23.0

66.8

17.8

29.7

52.5

 < 20 g/day

17.3

35.7

47.0

7.0

22.6

70.5

7.0

21.9

71.0

12.9

28.7

58.4

 ≥20 g/day

16.3

36.3

47.5

6.5

21.3

72.1

7.6

21.6

70.8

13.0

28.8

58.2

 Unknown

19.7

31.8

48.5

8.5

25.8

65.8

9.0

22.4

68.5

16.9

31.3

51.9

Estimated 5-year risk (at baseline) by Gail model (%)

 Lowest quintile (0.2–0.9)

24.2

36.0

39.8

9.9

28.0

62.1

10.8

27.1

62.1

22.9

41.7

35.4

 Second quintile (1.0–1.2)

15.3

37.2

47.5

8.6

24.9

66.5

11.5

24.8

63.7

20.4

28.8

50.8

 Third quintile (1.3–1.5)

10.3

34.2

55.4

7.5

22.5

70.0

8.4

23.9

67.7

20.2

32.4

47.3

 Fourth quintile (1.6–1.9)

8.6

29.3

62.1

6.2

21.0

72.7

8.7

22.6

68.6

17.5

30.2

52.4

 Highest quintile (2.0–11.4)

6.8

23.6

69.5

4.9

16.3

78.7

7.1

20.6

72.3

12.3

28.2

59.6

  1. Abbreviations: BMI Body Mass Index, HT Hormone therapy
  2. *All p-values from chi square tests for association between mammography frequency and characteristics in each age group are ≤0.05
  3. aBMI category: Underweight or normal (< 25 kg/m2), Overweight (25–29.9 kg/m2), Obese (≥30 kg/m2)